|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLTZ) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia显示文摘 | ROSENSTOCKJ SEMAN LJ JELASKA A | 2013 | Diabetes Obes Metab2013，，12： | 1 |
| 2 | Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes显示文摘 | Rosenstock J Jelaska A Frappin G | 2014 | Diabetes Care2014，37，7： | 1 |
| 3 | Role of apoptosis and transforming growthfactor betal in fibroblast selection and activation in systemic sclerosis显示文摘 | Jelaska A Korn JH | 2000 | Arthritis Rheum2000，43，10： | 1 |
| 4 | Fibroblast heterogeneity in physiological conditions and fibrotic disease显示文摘 | JELASKA A STREHLOW D KORN J H | 2000 | Springer Semin Immunopathol2000，21，4： | 1 |
| 5 | Impactof empagliflozin added-on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo- controlled trial显示文摘 | Rosenstock J Jelaska A Zeller C Kim G Broedl UC Woerle HJ | 2015 | Diabetes Obes Metab2015，17，10： | 1 |
| 6 | Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts Increased proportion of high collagen-producing cells in systemic sclerosis fibro- blasts 显示文摘 | Jelaska A Arakawa M Broketa G | 1996 | Arthritis Rheum1996，39，： | 1 |
| 7 | Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes显示文摘 | Rosenstock J Jelaska A Frappin G Salsali A Kim G Woerle H J Broedl UC | 2014 | Diabetes Care2014，37，： | 1 |
| 8 | Role of apoptosis and transforming growthfactor betal in fibroblast selection and activation in systemic sclerosis显示文摘 | Jelaska A Korn JH | 2000 | Arthritis Rheum2000，43，10： | 1 |
| 9 | Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empaglifloziq added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes 显示文摘 | Rosenstock J Jelaska A | 2014 | Diabetes Care2014，37，7： | 1 |
| 10 | Human mast cells activate fibroblasts:tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis显示文摘 | Gruber BL Kew RR Jelaska A | 1997 | J Immunol1997，158，5： | 1 |
| 11 | Role of apoptosis and transforming growthfactor betal in fibroblast selection and activation in systemic sclerosis显示文摘 | Jelaska A Kom JH | 2000 | Arthritis Rheum2000，43，10： | 1 |
| 12 | Relative sea-level changes recorded on an isolated carbonate platform: Tithonian to Cenomanian succession, Southern Croatia 显示文摘 | Husinec A Jelaska V | 2006 | Journal of Sedimentary Research2006，76，10： | 1 |
| 13 | ttuman mast cells ac- tivate fil)roblasts: Ttyptase is a fibrogenic faclor stimulatingcollagen messenger ribonucleic acid synthesis and fibroblast chemotaxis 显示文摘 | Cruber BI Kew RR Jelaska A | 1997 | J Immunol1997，158，5： | 1 |
| 14 | Efficacy and safety of empagliflozin, a sodium glucose cotrans- porter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycemia显示文摘 | Rosenstock J Seman LH Jelaska A | 2013 | Diabetes Obes Metab2013，15，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员